Pain Killer, Anxiety and Mucogingival Therapy

University of Liege40 enrolled

Overview

Is the pain killer consumption after gingival treatment related to the level of patient anxiety or to the type of therapy?

Anxiety and depression (HAD) scale used could be reveal the level of the patient anxiety and/or depression before intervention. Additionnaly the use of these specific questionnaires (7 items for anxiety, 7 items for depression) could reveal if the pain killer consumption after gingical treatment is dependant to the level of HAD or to the therapy . This tool (HAD) could allows to recognize, before any (oral)surgery, profil with high risk and propose solution to decrease anxiety and/or depression before treatment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

SINGLE

Enrollment

Conditions

Anxiety and Depression

Interventions

gingival graftPROCEDURE

investigators: Donor site: * tissue graft harvesting from the palate behind the palatal rugae . * placement of a palatine hemostatic plaque on the palate in order to reduce the risk of bleeding and to diminish the postoperative pain. Received site: * Control: the horizontal incision adjacent to the recession(s) and vertical incisions and split thickness flap. Placement of the graft on the recipient bed and suture. * Test :connective tissue graft using the " envelope/pouch " technique with two partial thickness incisions (deep and superficial). Placement of the graft inside the envelope

Eligibility

Sex: ALLMin age: 18 YearsMax age: 99 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * ASA type I and II subjects * Localized Gingival Recessions * Recessions Cairo RT I-II * FMPS \< 10% * FMBS\< 10% * \<10 cigs/ day * No contra-indication against oral surgical interventions * Patient is able to give inform consent Exclusion Criteria: * Infection (local or systemic). Each infection will be evaluated prior to study procedure for suitability. Patients with gingivitis or local infection (fracture, apical reaction) will undergo a dental treatment prior to his entrance to the study. In case of systemic infection, the evaluation will be based on medical anamneses, and if necessary will be referred to relevant medical tests. * ASA type \> II * Current pregnancy or breastfeeding women * Alcoholism or chronically drug abuse * Smokers, ≳ 10 cigarettes per day * Immunocompromised patients * Uncontrolled diabetes * Untreated periodontitis * History of previous periodontal surgery (mucogingival or other) on the teeth to be included * Presence of severe tooth malposition, rotation or significant version of the tooth to be treated

Locations (1)

leila Salhi

Liège, Liege, Belgium

RECRUITING

Outcomes

Primary Outcomes

pin killer consumption

the number of pain killer used after treatment

Time frame: two weeks

Central Contacts

leila Salhi, PhD

CONTACT

0484888091 l.salhi@chuliege.be

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.